Blueprint Medicines Competitors and Similar CompaniesClear all

Halozyme Therapeutics's competitors and similar companies include Deciphera Pharmaceuticals, Repare Therapeutics and Ohm Oncology.
Halozyme Therapeutics
Halozyme Therapeutics
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
Repare Therapeutics
Repare Therapeutics
Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.
Ohm Oncology
Ohm Oncology
Ohm Oncology is a drug development company committed to treating drug-resistant neoplasms and cancers with multi-mechanism compounds.
Founding Date
Founding Date
1998
Founding Date
2003
Founding Date
2016
Founding Date
2015
Type
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
San Diego, US HQ
Locations
Waltham, US HQ
Lawrence, US
Locations
Montréal, CA HQ
Cambridge, US
Locations
Austin, US HQ
Employees
Employees
373157% increase
Employees
35037% increase
Employees
1791% decrease
Employees
167% decrease
Valuation ($)
Valuation ($)
5.2 b
Valuation ($)
1.3 b
Valuation ($)
173.4 m
Valuation ($)
N/A
Twitter followers
Twitter followers
423
Twitter followers
783
Twitter followers
1 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.8
Average likes per tweet (last 30 days)
1.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
88.89%
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A

Financial

Revenue (est.)
Revenue (est.)
$829.3m (FY, 2023)
Revenue (est.)
$163.4m (FY, 2023)
Revenue (est.)
$135k (FY, 2020)
Revenue (est.)
N/A
Cost of goods
Cost of goods
$192.4m (FY, 2023)
Cost of goods
$3.7m (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$636.9m (FY, 2023)
Gross profit
$159.6m (FY, 2023)
Gross profit
$135k (FY, 2020)
Gross profit
N/A
Net income
Net income
$281.6m (FY, 2023)
Net income
($194.9m) (FY, 2023)
Net income
($53.4m) (FY, 2020)
Net income
N/A

Operating

Patent Applications
Patent Applications
50 (FY, 2020)
Patent Applications
49 (Aug, 2017)
Patent Applications
N/A
Patent Applications
N/A
Patents (US)
Patents (US)
43 (FY, 2020)
Patents (US)
11 (Aug, 2017)
Patents (US)
N/A
Patents (US)
N/A

Funding

Total funding raised
Total funding raised
$ 171.9m
Total funding raised
$ 714m
Total funding raised
$ 150.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Deciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.

View company
Repare Therapeutics
HQ
Montréal, CA
Employees
179↓ 1% decrease

Repare Therapeutics is a company that develops oncology drugs for patients that target specific vulnerabilities of tumor cells.

View company
Ohm Oncology
HQ
Austin, US
Employees
1

Ohm Oncology is a drug development company committed to treating drug-resistant neoplasms and cancers with multi-mechanism compounds.

View company